Iron supplement C — Competitive Intelligence Brief

Iron supplement C (Iron supplement C) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Iron (Fe2+/Fe3+) Hematology Small molecule

Target snapshot

Iron supplement C (Iron supplement C) — Tanabe Pharma Corporation. Iron supplement C replenishes iron stores to treat or prevent iron deficiency anemia by providing bioavailable iron for hemoglobin synthesis.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iron supplement C TARGET	Iron supplement C	Tanabe Pharma Corporation	marketed	Iron supplement	Iron (Fe2+/Fe3+)
Ferric Maltol (Feraccru®)	Ferric Maltol (Feraccru®)	Pharmanutra S.p.a.	marketed	Iron supplement	Iron (Fe³⁺) delivery via maltol chelation
Ferric Pyrophosphate Liposomal	Ferric Pyrophosphate Liposomal	All India Institute of Medical Sciences	marketed	Iron supplement
Iron protein succinylate oral solution	Iron protein succinylate oral solution	Lee's Pharmaceutical Limited	marketed	Iron supplement
Fisiogen Ferro Forte	Fisiogen Ferro Forte	Hospital Universitari Vall d'Hebron Research Institute	marketed	Iron supplement	Iron (Fe2+/Fe3+)
elemental iron (NovaFerrum®)	elemental iron (NovaFerrum®)	University of Texas Southwestern Medical Center	marketed	Iron supplement	Iron (Fe2+/Fe3+) — cofactor for hemoglobin and myoglobin synthesis
ferrous gluconate with lactoferrin	ferrous gluconate with lactoferrin	Ain Shams University	marketed	Iron supplement with immunomodulatory adjuvant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class